NOVAVAX INC Operating Leases, Future Minimum Payments, Due in Five Years
NOVAVAX INC (NVAX) had Operating Leases, Future Minimum Payments, Due in Five Years of $8.71 million as of 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2016-11-09
- 2016-09-30: Operating Leases, Future Minimum Payments, Due in Five Years $8.71M.
- 2016-06-30: Operating Leases, Future Minimum Payments, Due in Five Years $8.72M.
- 2016-03-31: Operating Leases, Future Minimum Payments, Due in Five Years $8.27M.
- 2015-09-30: Operating Leases, Future Minimum Payments, Due in Five Years $4.31M.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2016-09-30 | $8.71M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $8.72M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $8.27M 10-Q · filed 2016-05-05 |
| 2015-09-30 | $4.31M 10-Q · filed 2015-11-09 |
| 2013-12-31 | $2.43M 10-K · filed 2014-03-12 |
| 2012-12-31 | $2.44M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |